Just One Good Thing - ARPA-H's Moonshot Against Cancer

Just One Good Thing: Daily Political News about the 2024 Election, Kamala Harris and Democratic Achievements.

This episode explores how the Biden-Harris administration's Advanced Research Projects Agency for Health (ARPA-H) is revolutionizing cancer research and treatment. From developing precision surgical tools to investing in early detection technologies, ARPA-H is driving innovation to achieve the Cancer Moonshot goal of halving cancer deaths in 25 years. The discussion highlights how this approach contrasts with the previous administration's policies, which often threatened to undermine cancer research and treatment access.

Here's what to do:
Check vote.org to make sure you and your friends' voter registrations are up to date.

Fact-checking quotes:

1. "ARPA-H is paving the way for unprecedented and groundbreaking research on cancer. This work will be a pillar in this Administration's ambitious and important goal to cut the cancer death rate in half in 25 years," said HHS Secretary Xavier Becerra.
2. "ARPA-H's new Precision Surgical Interventions (PSI) program aims to deliver groundbreaking new tools to enable surgeons to successfully remove cancer for patients through a single operation by better identifying and differentiating between healthy and cancer tissue."
3. "As ARPA-H continues to fund critical research in hopes of solving tough challenges like ending cancer and improving women's health, I'm often asked, 'Why ARPA-H?' As a health catalyst that can bring together major players across the health ecosystem, ARPA-H is uniquely positioned to support the development of breakthroughs that cannot be readily accomplished through traditional research and commercial activity."